Literature DB >> 1008826

Human liver glycogen phosphorylase. Kinetic properties and assay in biopsy specimens.

B Lederer, W Stalmans.   

Abstract

1. The two forms of glycogen phosphorylase were purified from human liver, and some kinetic properties were examined in the direction of glycogen synthesis. The b form has a limited catalytic capacity, resembling that of the rabbit liver enzyme. It is characterized by a low affinity for glucose 1-phosphate, which is unaffected by AMP, and a low V, which becomes equal to that of the a form in the presence of the nucleotide. Lyotropic anions stimulate phosphorylase b and inhibit phosphorylase a by modifying the affinity for glucose 1-phosphate. Both enzyme forms are easily saturated with glycogen. 2. These kinetic properties have allowed us to design a simple assay method for total (a + b) phosphorylase in human liver. It requires only 0.5 mg of tissue, and its average efficiency is 90% when the enzyme is predominantly in the b form. 3. The assay of total phosphorylase allows the unequivocal diagnosis of hepatic glycogen-storage disease caused by phosphorylase deficiency. One patient with a complete deficiency is reported. 4. The assay of human liver phosphorylase a is based on the preferential inhibition of the b form by caffeine. The a form displays the same activity when measured by either of the two assays.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008826      PMCID: PMC1164170          DOI: 10.1042/bj1590689

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  [Enzymatic studies of hepatic fragments; application to the classification of glycogenoses].

Authors:  H G HERS
Journal:  Rev Int Hepatol       Date:  1959

2.  Comparative studies on glycogen phosphorylase. II. Immunological studies on rabbit and human skeletal muscle phosphorylase.

Authors:  A A YUNIS; E G KREBS
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

3.  Crystallization and properties of human muscle phosphorylases a and b.

Authors:  A A YUNIS; E H FISCHER; E G KREBS
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

4.  Comparative studies on glycogen phosphorylase. III. The phosphorylated site in human muscle phosphorylase alpha.

Authors:  R C HUGHES; A A YUNIS; E G KREBS; E H FISCHER
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

Review 5.  The role of the liver in the homeostasis of blood glucose.

Authors:  W Stalmans
Journal:  Curr Top Cell Regul       Date:  1976

6.  [Heterogeneity of glycogenosis type VI. Study of leukocyte phosphorylase activity in 2 families].

Authors:  P Guibaud; M Mathieu
Journal:  Arch Fr Pediatr       Date:  1972-12

7.  The interaction of liver phosphorylase a with glucose and AMP.

Authors:  W Stalmans; M Laloux; H G Hers
Journal:  Eur J Biochem       Date:  1974-11-15

8.  Hepatic phosphorylase deficiency. Its differentiation from other hepatic glycogenoses.

Authors:  J Fernandes; J F Koster; W F Grose; N Sorgedrager
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

9.  Radioactive method for the assay of glycogen phosphorylases.

Authors:  D P Gilboe; K L Larson; F Q Nuttall
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

10.  Liver phosphorylase deficiency in glycogenosis type VI: documentation by biochemical analysis of hepatic biopsy specimens.

Authors:  G Hug; G Chuck; L Walling; W K Schubert
Journal:  J Lab Clin Med       Date:  1974-07
View more
  9 in total

1.  Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

Authors:  B Burwinkel; H D Bakker; E Herschkovitz; S W Moses; Y S Shin; M W Kilimann
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

2.  Radiochemical methods for the assay of phosphorylase in the direction of glycogenolysis.

Authors:  G Gevers; W Stalmans
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

3.  Glycogen phosphorylase isoenzymes from hepatoma 3924A and from a non-tumorigenic liver cell line. Comparison with the liver and brain enzymes.

Authors:  D Mayer; G Seelmann-Eggebert; I Letsch
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

4.  Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

Authors:  Lindsay C Burrage; Simran Madan; Xiaohui Li; Saima Ali; Mahmoud Mohammad; Bridget M Stroup; Ming-Ming Jiang; Racel Cela; Terry Bertin; Zixue Jin; Jian Dai; Danielle Guffey; Milton Finegold; Sandesh Nagamani; Charles G Minard; Juan Marini; Prakash Masand; Deborah Schady; Benjamin L Shneider; Daniel H Leung; Deeksha Bali; Brendan Lee
Journal:  JCI Insight       Date:  2020-02-27

5.  Glycogen synthesis by rat hepatocytes.

Authors:  J Katz; S Golden; P A Wals
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

6.  The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.

Authors:  C B Newgard; R J Fletterick; L A Anderson; R V Lebo
Journal:  Am J Hum Genet       Date:  1987-04       Impact factor: 11.025

7.  Stimulation of glycogenolysis in isolated hepatocytes by adenosine and one of its analogues is inhibited by caffeine.

Authors:  J C Stanley; J Markovic; A M Gutknecht; F J Lozeman
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

8.  High frequency of missense mutations in glycogen storage disease type VI.

Authors:  N J Beauchamp; J Taybert; M P Champion; V Layet; P Heinz-Erian; A Dalton; M S Tanner; E Pronicka; M J Sharrard
Journal:  J Inherit Metab Dis       Date:  2007-08-21       Impact factor: 4.982

9.  The catalytic activity of phosphorylase b in the liver. With a note on the assay in the glycogenolytic direction.

Authors:  W Stalmans; G Gevers
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.